Compass Therapeutics, Inc. (CMPX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.29
Day's range
$5.52

Compass Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TANG CAPITAL MANAGEMENT LLC 08/14/2026 17.99 M $39.40 M   7.15% 9.63%
ORBIMED ADVISORS LLC 08/14/2026 15.22 M $33.33 M   0.00% 8.15%
SUVRETTA CAPITAL MANAGEMENT, LLC 08/14/2026 14.10 M $30.88 M   -1.44% 7.55%
BLACKROCK, INC. 08/07/2026 11.28 M $24.71 M   18.68% 6.04%
STATE STREET CORP 09/22/2026 9.95 M $21.80 M   48.67% 5.33%
ENAVATE SCIENCES GP, LLC 08/14/2026 7.79 M $17.06 M   0.00% 4.17%
VIVO CAPITAL, LLC 08/14/2026 7.76 M $16.99 M   -18.74% 4.15%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 6.12 M $13.40 M   1.35% 3.28%
PALO ALTO INVESTORS LP 08/19/2026 5.83 M $12.77 M   285.06% 3.12%
MILLENNIUM MANAGEMENT LLC 08/14/2026 4.71 M $10.32 M   456.98% 2.52%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 3.82 M $8.36 M   6.99% 2.04%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 3.77 M $8.26 M   248.31% 2.02%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 3.69 M $8.08 M   44.59% 1.97%
BLUE OWL CAPITAL HOLDINGS LP 08/11/2026 3.62 M $7.94 M   23.20% 1.94%
CITADEL ADVISORS LLC 09/02/2026 3.57 M $7.82 M   394.96% 1.91%
GOLDMAN SACHS GROUP INC 08/14/2026 3.53 M $7.73 M   76.96% 1.89%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 3.52 M $7.72 M   6.64% 1.89%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 3.51 M $7.69 M   1,650.82% 1.88%
BIRCHVIEW CAPITAL, LP 08/14/2026 1.68 M $3.67 M   14.27% 0.90%
KINGDON CAPITAL MANAGEMENT, L.L.C. 08/14/2026 1.40 M $3.07 M   100.00% 0.75%
FISHER ASSET MANAGEMENT, LLC 08/04/2026 1.39 M $3.05 M   3.24% 0.75%
ROYCE & ASSOCIATES LP 08/14/2026 1.34 M $2.93 M   -17.47% 0.72%
FMR LLC 08/13/2026 1.21 M $2.65 M   -32.72% 0.65%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 1.19 M $2.60 M   -86.02% 0.64%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 1.16 M $2.54 M   100.00% 0.62%
NORTHERN TRUST CORP 08/13/2026 1.14 M $2.50 M   8.81% 0.61%
HEALTHINVEST PARTNERS AB 07/24/2026 1.05 M $2.30 M   2,406.74% 0.56%
NUVEEN, LLC 08/11/2026 1.01 M $2.21 M   247.31% 0.54%
SQUAREPOINT OPS LLC 08/14/2026 1.01 M $2.21 M   1,906.91% 0.54%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.00 M $2.19 M   0.28% 0.54%
BLACKSTONE INC. 08/14/2026 899.94 K $1.97 M   -51.56% 0.48%
FIRST TRUST ADVISORS LP 08/11/2026 807.00 K $1.77 M   100.00% 0.43%
JPMORGAN CHASE & CO 08/12/2026 789.40 K $1.71 M   -6.88% 0.42%
KVP CAPITAL ADVISORS, LP 08/13/2026 771.00 K $1.69 M   54.20% 0.41%
MORGAN STANLEY 08/13/2026 735.19 K $1.61 M   104.01% 0.39%
CITIGROUP INC 08/03/2026 713.91 K $1.56 M   19.33% 0.38%
UBS GROUP AG 08/13/2026 712.76 K $1.56 M   -70.19% 0.38%
BURKEHILL GLOBAL MANAGEMENT, LP 08/14/2026 700.00 K $1.53 M   0.00% 0.37%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 686.58 K $1.50 M   100.00% 0.37%
ACUTA CAPITAL PARTNERS, LLC 08/14/2026 595.21 K $1.30 M   -29.90% 0.32%
BANK OF AMERICA CORP /DE/ 08/14/2026 566.92 K $1.24 M   -34.51% 0.30%
CM MANAGEMENT, LLC 08/13/2026 550.00 K $1.20 M   100.00% 0.29%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 541.18 K $1.18 M   23.06% 0.29%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 523.78 K $1.15 M   5.21% 0.28%
ARTIA GLOBAL PARTNERS LP 08/14/2026 383.20 K $839.21 K   100.00% 0.21%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 378.69 K $829.32 K   5.15% 0.20%
ARROWMARK COLORADO HOLDINGS LLC 08/13/2026 364.74 K $798.79 K   -29.15% 0.20%
BANK OF NEW YORK MELLON CORP 08/06/2026 351.03 K $768.76 K   18.07% 0.19%
MARSHALL WACE, LLP 08/13/2026 334.87 K $733.36 K   100.00% 0.18%
TWO SIGMA INVESTMENTS, LP 08/14/2026 320.31 K $701.48 K   867.71% 0.17%

Compass Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 277 institutional investors and hedge funds held shares of Compass Therapeutics Inc. The most heavily invested institutionals were:

Wealth Enhancement Trust Services, Inc.: 0

TANG CAPITAL MANAGEMENT LLC: 17.99 M

ORBIMED ADVISORS LLC: 15.22 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 14.1 M

BlackRock, Inc.: 11.28 M

STATE STREET CORP: 9.95 M

88.87% of Compass Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 185.46 M shares in the last 24 months. This purchase volume represents approximately $1.01 B in transactions.